126 related articles for article (PubMed ID: 10763143)
1. EORTC external quality assurance program for ER and PgR measurements: trial 1998/1999. European Organisation for Research and Treatment of Cancer.
Sweep CG; Geurts-Moespot J
Int J Biol Markers; 2000; 15(1):62-9. PubMed ID: 10763143
[TBL] [Abstract][Full Text] [Related]
2. Twenty years of experience with the steroid receptor external quality assessment program - the paradigm for tumour biomarker EQA studies. On behalf of the EROTC Receptor and Biomarker Study Group.
Geurts-Moespot J; Leake R; Benraad TJ; Sweep CG
Int J Oncol; 2000 Jul; 17(1):13-22. PubMed ID: 10853012
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study.
Elledge RM; Green S; Pugh R; Allred DC; Clark GM; Hill J; Ravdin P; Martino S; Osborne CK
Int J Cancer; 2000 Mar; 89(2):111-7. PubMed ID: 10754487
[TBL] [Abstract][Full Text] [Related]
4. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay].
Morimoto K; Hasuma T; Koh M; Ohtani S; Kinoshita H
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1597-605. PubMed ID: 12355945
[TBL] [Abstract][Full Text] [Related]
5. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group.
Romain S; Lainé Bidron C; Martin PM; Magdelenat H
Eur J Cancer; 1995; 31A(3):411-7. PubMed ID: 7786610
[TBL] [Abstract][Full Text] [Related]
6. Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts.
Luqmani YA; Temmim L; Memon A; Ali MA; Parkar AH
Int J Cancer; 1997 May; 71(4):526-38. PubMed ID: 9178804
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients.
Elledge RM; Ciocca DR; Langone G; McGuire WL
Cancer; 1993 Apr; 71(8):2499-506. PubMed ID: 8095853
[TBL] [Abstract][Full Text] [Related]
8. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
Encarnación CA; Ciocca DR; McGuire WL; Clark GM; Fuqua SA; Osborne CK
Breast Cancer Res Treat; 1993; 26(3):237-46. PubMed ID: 8251648
[TBL] [Abstract][Full Text] [Related]
9. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
10. Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre study.
Gion M; Dittadi R; Leon AE; Bruscagnin G; Pelizzola D; Giovannini G; Giganti M; Messeri G; Quercioli M; Flamini E
Eur J Cancer; 1991; 27(8):996-1002. PubMed ID: 1832912
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
[TBL] [Abstract][Full Text] [Related]
12. Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences.
Romain S; Formento JL; Guirou O; Francoual M; Milano G; Martin PM
Eur J Cancer; 1994; 30A(6):740-6. PubMed ID: 7917530
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.
Harvey JM; Clark GM; Osborne CK; Allred DC
J Clin Oncol; 1999 May; 17(5):1474-81. PubMed ID: 10334533
[TBL] [Abstract][Full Text] [Related]
14. Hormonal receptor determination of 1,052 Chinese breast cancers.
Chow LW; Ho P
J Surg Oncol; 2000 Nov; 75(3):172-5. PubMed ID: 11088048
[TBL] [Abstract][Full Text] [Related]
15. Standardization of steroid receptor assays in human breast cancer--IV. Long-term within- and between-laboratory variation of estrogen and progesterone receptor assays.
Koenders A; Thorpe SM
Eur J Cancer Clin Oncol; 1986 Aug; 22(8):945-52. PubMed ID: 3770052
[TBL] [Abstract][Full Text] [Related]
16. NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry.
Allred DC; Carlson RW; Berry DA; Burstein HJ; Edge SB; Goldstein LJ; Gown A; Hammond ME; Iglehart JD; Moench S; Pierce LJ; Ravdin P; Schnitt SJ; Wolff AC
J Natl Compr Canc Netw; 2009 Sep; 7 Suppl 6():S1-S21; quiz S22-3. PubMed ID: 19755043
[TBL] [Abstract][Full Text] [Related]
17. Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation.
Andersen J; Bentzen SM; Poulsen HS
Eur J Cancer Clin Oncol; 1988 Mar; 24(3):377-84. PubMed ID: 3289941
[TBL] [Abstract][Full Text] [Related]
18. Determination of estrogen and progesterone receptors in human breast cancer cytosols: a comparison between radioligand binding assay (DCC) and enzyme immunoassay (EIA).
Cerra M; Cecco L; Montella M; Celentano E; Bonelli P; Tuccillo F
Int J Biol Markers; 1996; 11(1):50-2. PubMed ID: 8740643
[No Abstract] [Full Text] [Related]
19. Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors.
Redkar AA; Kabre SS; Mittra I
Indian J Med Res; 1992 Feb; 96():1-8. PubMed ID: 1597324
[TBL] [Abstract][Full Text] [Related]
20. Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancer.
Mobbs BG; Johnson IE
J Steroid Biochem; 1987 Dec; 28(6):653-62. PubMed ID: 3320574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
